Objective Neuromyelitis optica (NMO) attacks often are severe, are difficult to treat, and leave
residual deficits. Here, we analyzed the frequency, sequence, and efficacy of therapies …

Objective To report pregnancy outcomes and disease activity (DA) in women with MS,
neuromyelitis optica spectrum disorders (NMOSDs), and other neuroimmunologic diseases (ONID…

Objective To assess clinical characteristics, distribution of disease-modifying treatments (DMTs),
and neuropsychological symptoms in a large cohort of patients with early-stage MS. …

Fumaric acid, first applied topically in psoriasis, has also been used orally since the mid-1980s.
A preparation of dimethyl fumarate, BG-12, reduces disease activity in multiple sclerosis (…

Background In multiple sclerosis (MS), neurological disability results from incomplete
remission of relapses and from relapse-independent progression. Intravenous high dose …

Objective To investigate whether consolidation after motor learning can be facilitated by
offline (post-training) transcranial direct current stimulation (tDCS) in patients with multiple …

Background Fatigue is common in multiple sclerosis (MS) patients. Exhaustion of
physiological reserves and mental stress are postulated causes, the latter supported by more …

The central noradrenaline (NA) stress-response network co-mediates hypothalamic-pituitary-adrenal
(HPA) axis activation and arginine-vasopressin (AVP) release. Dysregulation of …

The neurotransmitter noradrenaline (NA) mediates arousal, attention and mood, and exerts
anti-inflammatory and neuroprotective effects. Alterations of monoamine signalling were …

Context Increased activities of the arginine-vasopressin (AVP) system and the hypothalamic-pituitary-adrenal
(HPA) axis were shown to be associated with human obesity, but …